[go: up one dir, main page]

AU2003280693A1 - Prostate cancer tumor marker - Google Patents

Prostate cancer tumor marker

Info

Publication number
AU2003280693A1
AU2003280693A1 AU2003280693A AU2003280693A AU2003280693A1 AU 2003280693 A1 AU2003280693 A1 AU 2003280693A1 AU 2003280693 A AU2003280693 A AU 2003280693A AU 2003280693 A AU2003280693 A AU 2003280693A AU 2003280693 A1 AU2003280693 A1 AU 2003280693A1
Authority
AU
Australia
Prior art keywords
prostate cancer
tumor marker
cancer tumor
marker
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280693A
Inventor
Masamichi Ueda
Tatsuhiro Yoshiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TSS Biotech Inc
Original Assignee
TSS Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TSS Biotech Inc filed Critical TSS Biotech Inc
Publication of AU2003280693A1 publication Critical patent/AU2003280693A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/57555—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003280693A 2002-10-31 2003-10-31 Prostate cancer tumor marker Abandoned AU2003280693A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002317348 2002-10-31
JP2002-317348 2002-10-31
PCT/JP2003/014015 WO2004039844A1 (en) 2002-10-31 2003-10-31 Prostate cancer tumor marker

Publications (1)

Publication Number Publication Date
AU2003280693A1 true AU2003280693A1 (en) 2004-05-25

Family

ID=32211716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280693A Abandoned AU2003280693A1 (en) 2002-10-31 2003-10-31 Prostate cancer tumor marker

Country Status (3)

Country Link
JP (1) JP4451784B2 (en)
AU (1) AU2003280693A1 (en)
WO (1) WO2004039844A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6893406B2 (en) * 2016-10-19 2021-06-23 日本化薬株式会社 Testing method for progress of NASH and NAFLD and testing method for inflammatory diseases and cancer
EP3995829A1 (en) * 2020-11-09 2022-05-11 MediaPharma S.r.l. Lgals3bp as a diagnostic, prognostic, and therapeutic biomarker in covid-19 and other cytokine storm conditions

Also Published As

Publication number Publication date
JP4451784B2 (en) 2010-04-14
JPWO2004039844A1 (en) 2006-03-02
WO2004039844A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003294205A1 (en) Prostate cancer biomarkers
AU2001253140A1 (en) Tumor markers in ovarian cancer
AUPS054702A0 (en) Cancer therapy
AU2002361908A1 (en) Methods for identifying marker genes for cancer
AU2003235470A1 (en) Predictive markers in cancer therapy
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2002362454A1 (en) Regulated breast cancer genes
AU2003293194A1 (en) Compositions and methods for treating prostate cancer
AU2003224076A1 (en) Antibody combination useful for tumor therapy
AU2002335640A1 (en) Gleason grade 4/5 prostate cancer genes
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
AU2002360345A1 (en) Prostate cancer genes
AU2001270082A1 (en) Gene markers for lung cancer
AU2003286645A1 (en) Antibody-mediated induction of tumor cell death
AU2003289603A1 (en) Tumor vaccine
AU2002307154A1 (en) Prostate cancer expression profiles
AU2003214944A1 (en) Secreted caveolin as a marker for prostate cancer
AU2003212826A1 (en) Cancer genes
AU2003283339A1 (en) Cancer therapy determination
AU2003280693A1 (en) Prostate cancer tumor marker
AU2003261166A1 (en) Liver tumor marker sequences
AU2003238722A1 (en) Cancer therapy by modulating cdc42-activity
AU2003301986A1 (en) Knock-in mouse prostate cancer model
AU2002351382A1 (en) Combination cancer therapy
AU2003271457A1 (en) Methods for detecting prostate cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase